Acromegaly - Before and After Treatment
Acromegaly - Before and After Treatment
The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly
 before and after surgery and/or medical treatment.
Acromegaly is a rare disease caused by a growth hormone (GH) producing pituitary adenoma.
 Surgery is primary treatment, whereas medical treatment with a somatostatin analogue (SA),
 which suppresses GH secretion and reduces tumour size, is used when surgery is insufficient
 or unfeasible. Acromegaly is associated with metabolic abnormalities which contributes to an
 increased morbidity and mortality if left untreated. To which extend these abnormalities
 reverses after treatment, and if treatment modality influences the outcome, remain elusive.
 The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly
 before and after surgery and/or medical treatment
Inclusion Criteria:

 -  Recently diagnosed with acromegaly

 -  Age above 18

 -  Written consent

 Exclusion Criteria:

 - Pregnancy